Surgical Innovations Group plc (SUN)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 0.400 |
|---|---|
| 52-week range | 0.330 – 0.600 |
| Return, 1 month / 3 months | −5.9% / −20.0% |
| Return, 1 year / 3 years | −30.4% / −60.0% |
| Trend | Below its 200-day average |
| RSI (14) | 1 |
| Volatility (1 year) | 27.8% |
| Worst drawdown (1 year) | -30.4% |
| Average daily value traded | 0.25M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Surgical Innovations Group designs and makes instruments used in minimally invasive, or keyhole, surgery. Its products include laparoscopic ports, graspers, scissors and related hand instruments, sold under its own brands and made for other medical device firms. Customers are hospitals, surgeons and healthcare distributors, mainly in the United Kingdom and overseas markets. The company is based in Leeds, England, and its devices are used in procedures such as gallbladder and other abdominal operations.
On this site Surgical Innovations Group plc appears as a stock on the London Exchange (UK), code SUN, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Surgical Innovations Group plc (SUN) trades on the London Exchange in UK. It last closed at GBX 0.400 on 23 October 2026.
Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 2,851 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 30.4% and over the last three months it fell 20.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.5% | ||
| From 52-week high | -30.4% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.0% | ||
| 6-month return | -11.1% | ||
| 12-month return, skipping the last month | -26.1% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.4% | ||
| Liquidity | 39 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.25M GBX | ||
| Zero-volume days | 11.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −5.9% |
| 3 months | −20.0% |
| 6 months | −11.1% |
| 1 year | −30.4% |
| 3 years | −60.0% |
| 5 years | −83.0% |
Signals
| 50-day / 200-day average | 0.415 / 0.452 |
|---|---|
| Golden / death cross (60 days) | Death, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.041 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.